ArticleFuture oncology (London, England)2014

Tivozanib reverses multidrug resistance mediated by ABCB1 (P-glycoprotein) and ABCG2 (BCRP).

Danwen Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.